Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenocarcinoma of the Stomach × indusatumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Adenocarcinoma 1 Adenocarcinoma of the Stomach 1

Interventions

toripalimab 2 Oxaliplatin 2 tesetaxel 1 indusatumab 1 Trastuzumab 1 S 1 (combination) 1 Leucovorin 1 GC1118 1 Fluorouracil 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02202759 2017-05-15

A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction

Takeda

Phase 2 Terminated

38 enrolled 23 charts

Gastrointestinal

Adenocarcinoma of the Stomach

Data powered by HemOnc (CC BY 4.0) Colophon ⚡